FdaApplication

NDA 202450

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAZURITY PHARMACEUTICALS INC
application_typeNDA
approval_date2012-07-23

Products (1)

ProductActive ingredientStrengthDosage form
TUDORZA PRESSAIRACLIDINIUM BROMIDE0.4MG/INHPOWDER, METERED;INHALATION

1 product